Patents by Inventor Samuel A. Santoro

Samuel A. Santoro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antithrombotic peptides
    Patent number: 6083914
    Abstract: Novel short peptides are disclosed which are selected from the group consisting of TAVTQTYGGNSNGEP and fragments thereof containing the minimal sequence TATQTY. These peptides are antithrombotic agents and mediate divalent cation-independent adhesion of platelets to fibronectin.
    Type: Grant
    Filed: August 19, 1998
    Date of Patent: July 4, 2000
    Assignee: Washington University
    Inventors: Samuel A. Santoro, William D. Staatz
  • Antithrombotic peptides
    Patent number: 5932693
    Abstract: Novel short peptides are disclosed which are selected from the group consisting of TAVTQTYGGNSNGEP and fragments thereof containing the minimal sequence TAVTQTY. These peptides are antithrombotic agents and mediate divalent cation-independent adhesion of platelets to fibronectin.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: August 3, 1999
    Assignee: Washington University
    Inventors: Samuel A. Santoro, William D. Staatz
  • Inhibitory peptides against .alpha.-2, .beta.-1 mediated mg.sup.++ dependent adhesion of platelets to collagen
    Patent number: 5120830
    Abstract: Novel short peptides are disclosed which are selected from the group consisting of GPAGKDGEAGAQG and fragments thereof containing the minimal sequence Ala Gly Glu Ala. These peptides have inhibitory activity against .alpha..sub.2 .beta..sub.1 -mediated Mg.sup.++ -dependent adhesion of platelets to collagen.
    Type: Grant
    Filed: October 25, 1990
    Date of Patent: June 9, 1992
    Assignee: Washington University
    Inventor: Samuel A. Santoro